Mid Day Stock Buzz (GGP, HLF, KSS, BGMD)

Los Angelas, CA -- (SBWIRE) -- 01/03/2013 -- General Growth Properties Inc (NYSE:GGP) was down after Activist investor William Ackman’s Pershing Square Capital Management said it is not willing to force a sale of General Growth Properties Inc after it was unable to secure an offer for the No. 2 U.S. mall owner.

General Growth Properties, Inc. is a real estate investment trust (REIT). The Company was a real estate owner and operator of regional malls with an ownership interest in 136 regional malls in 41 states, comprising 58 million square feet of gross leasable area (GLA), excluding anchor tenants.

Can GGP Extend Rally? Find Out Here

Herbalife (NYSE:HLF) has risen 9% to hit a current price of $35.09 per share. So far today, the company's volume is 6.4 million shares, 0.3 times the current three-month average.

Herbalife Ltd. is a global network marketing company that sells weight management, nutritional supplements, energy, sports and fitness products and personal care products through a network of approximately 2.7 million independent distributors, except in China, where the Company sells its products through retail stores.

How Should Investors React To HLF Now? Find Out Here

Kohl's Corp. (NYSE:KSS) is down nearly 3 percent to $41.03. The company's comparable store sales rose 3.4 percent and total sales were up 4.0 percent for the month of December. The company noted that its December sales were lower than planned. The company also slashed its earnings per share outlook for its fourth quarter and full-year.

Kohl’s Corporation operate family-oriented department stores that sells apparel, footwear and accessories for women, men and children; soft home products, such as sheets and pillows, and housewares. Kohl’s apparel and home fashions appeal to classic, modern classic and contemporary customers.

Can KSS Move Up Further? If Yes, How far It can Go? Find Out Here

BG Medicine, Inc. (NASDAQ:BGMD) is up over 29 percent to $3.00 following the news that the first automated version of the BGM Galectin-3(R) blood test has obtained a CE Mark, an important step in its commercial strategy.

BG Medicine, Inc. is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests.

Is BGMD Showing Any Sign of Buy At The Current Market Price? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com